108 related articles for article (PubMed ID: 10518935)
1. Neurotoxicity of prion peptide 106-126 not confirmed.
Kunz B; Sandmeier E; Christen P
FEBS Lett; 1999 Sep; 458(1):65-8. PubMed ID: 10518935
[TBL] [Abstract][Full Text] [Related]
2. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
3. A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons.
Pillot T; Drouet B; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Chambaz J
J Neurochem; 2000 Dec; 75(6):2298-308. PubMed ID: 11080181
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
5. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
[TBL] [Abstract][Full Text] [Related]
7. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment.
Brown DR; Herms J; Kretzschmar HA
Neuroreport; 1994 Oct; 5(16):2057-60. PubMed ID: 7865744
[TBL] [Abstract][Full Text] [Related]
8. Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect.
Sáez-Valero J; Angeretti N; Forloni G
Neurosci Lett; 2000 Nov; 293(3):207-10. PubMed ID: 11036197
[TBL] [Abstract][Full Text] [Related]
9. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.
Brown DR; Schmidt B; Kretzschmar HA
Nature; 1996 Mar; 380(6572):345-7. PubMed ID: 8598929
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
[TBL] [Abstract][Full Text] [Related]
11. Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling.
Song Z; Yang W; Zhou X; Yang L; Zhao D
Neuropharmacology; 2017 Sep; 123():332-348. PubMed ID: 28545972
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity of a prion protein fragment.
Forloni G; Angeretti N; Chiesa R; Monzani E; Salmona M; Bugiani O; Tagliavini F
Nature; 1993 Apr; 362(6420):543-6. PubMed ID: 8464494
[TBL] [Abstract][Full Text] [Related]
13. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
[TBL] [Abstract][Full Text] [Related]
15. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
[TBL] [Abstract][Full Text] [Related]
16. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
17. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
Brown DR
Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of the putative transmembrane domain of the prion protein.
Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
[TBL] [Abstract][Full Text] [Related]
19. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
Brown DR; Herms JW; Schmidt B; Kretzschmar HA
Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
[TBL] [Abstract][Full Text] [Related]
20. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126).
Perovic S; Schröder HC; Pergande G; Ushijima H; Müller WE
Exp Neurol; 1997 Oct; 147(2):518-24. PubMed ID: 9344576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
